Free Trial

Crescent Capital BDC (CCAP) Financials

Crescent Capital BDC logo
$15.48 +0.31 (+2.05%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$15.47 -0.01 (-0.07%)
As of 04/17/2025 04:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Crescent Capital BDC

Annual Income Statements for Crescent Capital BDC

This table shows Crescent Capital BDC's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
84 -43 0.26 -16
Consolidated Net Income / (Loss)
79 -43 0.26 -16
Net Income / (Loss) Continuing Operations
79 -43 0.26 -16
Total Pre-Tax Income
79 -43 0.26 -16
Total Revenue
83 0.00 0.00 0.00
Net Interest Income / (Expense)
83 0.00 0.00 0.00
Total Interest Income
83 0.00 0.00 0.00
Total Interest Expense
0.00 0.00 0.00 0.00
Total Non-Interest Income
0.79 0.00 0.00 0.00
Net Realized & Unrealized Capital Gains on Investments
- 0.00 0.00 0.00
Total Non-Interest Expense
4.40 0.00 0.00 0.00
Nonoperating Income / (Expense), net
- -43 0.26 -16
Basic Earnings per Share
$1.67 $1.93 $2.30 $2.40
Weighted Average Basic Shares Outstanding
28.48M 30.89M 35.93M 37.06M
Diluted Earnings per Share
$1.67 $1.93 $2.30 $2.40
Weighted Average Diluted Shares Outstanding
28.48M 30.89M 35.93M 37.06M
Weighted Average Basic & Diluted Shares Outstanding
- 30.89M 37.06M 37.06M

Quarterly Income Statements for Crescent Capital BDC

This table shows Crescent Capital BDC's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
-18 -23 -9.93 1.41 0.98 7.80 4.35 -1.50 -1.77 -17
Consolidated Net Income / (Loss)
-18 -23 -9.93 1.41 0.98 7.80 4.35 -1.50 -1.77 -17
Net Income / (Loss) Continuing Operations
-18 -23 -9.93 1.41 0.98 7.80 4.35 -1.50 -1.77 -17
Total Pre-Tax Income
-18 -22 -9.93 1.41 0.98 7.80 4.35 -1.50 -1.77 -17
Total Revenue
0.00 -19 0.00 0.00 0.00 - 0.00 0.00 6.44 -6.44
Total Non-Interest Income
0.00 -25 0.00 0.00 0.00 - 0.00 0.00 6.44 -6.44
Net Realized & Unrealized Capital Gains on Investments
0.00 -25 0.00 0.00 0.00 - 0.00 0.00 6.44 -6.44
Nonoperating Income / (Expense), net
-18 - -9.93 1.41 0.98 7.80 4.35 -1.50 -8.22 -10
Basic Earnings per Share
$0.52 $0.52 $0.54 $0.56 $0.59 $0.61 $0.63 $0.59 $0.64 $0.54
Weighted Average Basic Shares Outstanding
30.89M 30.89M 32.47M 37.06M 37.06M 35.93M 37.06M 37.06M 37.06M 37.06M
Diluted Earnings per Share
$0.52 $0.52 $0.54 $0.56 $0.59 $0.61 $0.63 $0.59 $0.64 $0.54
Weighted Average Diluted Shares Outstanding
30.89M 30.89M 32.47M 37.06M 37.06M 35.93M 37.06M 37.06M 37.06M 37.06M
Weighted Average Basic & Diluted Shares Outstanding
30.89M 30.89M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M

Annual Cash Flow Statements for Crescent Capital BDC

This table details how cash moves in and out of Crescent Capital BDC's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Net Change in Cash & Equivalents
8.68 -6.46 7.40 15
Net Cash From Operating Activities
-158 28 92 59
Net Cash From Continuing Operating Activities
-158 28 92 59
Net Income / (Loss) Continuing Operations
84 16 84 74
Consolidated Net Income / (Loss)
84 16 84 74
Amortization Expense
-8.73 -5.12 -5.17 -6.46
Non-Cash Adjustments to Reconcile Net Income
-227 8.55 13 -10
Changes in Operating Assets and Liabilities, net
-5.35 8.97 0.66 2.04
Net Cash From Investing Activities
0.00 0.00 0.00 0.00
Net Cash From Continuing Investing Activities
0.00 0.00 0.00 0.00
Net Cash From Financing Activities
166 -34 -85 -43
Net Cash From Continuing Financing Activities
166 -34 -85 -43
Issuance of Debt
790 339 548 347
Issuance of Common Equity
53 0.00 0.00 0.00
Repayment of Debt
-629 -318 -565 -312
Repurchase of Common Equity
-0.52 0.00 0.00 0.00
Payment of Dividends
-48 -55 -65 -75
Other Financing Activities, Net
0.54 -0.22 -3.86 -3.43
Effect of Exchange Rate Changes
0.01 -0.01 0.09 -0.49
Cash Interest Paid
15 27 55 60
Cash Income Taxes Paid
2.18 1.97 0.67 1.34

Quarterly Cash Flow Statements for Crescent Capital BDC

This table details how cash moves in and out of Crescent Capital BDC's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
2.60 -4.39 17 -13 1.29 1.72 7.48 4.19 1.70 1.59
Net Cash From Operating Activities
-18 42 16 20 21 35 39 -25 47 -2.89
Net Cash From Continuing Operating Activities
-17 41 16 20 21 35 39 -25 47 -2.89
Net Income / (Loss) Continuing Operations
-2.38 2.60 7.78 23 23 31 28 20 15 9.99
Consolidated Net Income / (Loss)
-2.38 2.60 7.78 23 23 31 28 20 15 9.99
Amortization Expense
-0.89 -0.95 -1.38 -0.80 -1.22 -1.76 -1.79 -1.55 -1.82 -1.31
Non-Cash Adjustments to Reconcile Net Income
-13 38 20 -12 15 -9.29 21 -44 26 -14
Changes in Operating Assets and Liabilities, net
-1.04 1.29 -9.91 11 -15 15 -7.36 0.04 7.28 2.07
Net Cash From Financing Activities
21 -47 1.40 -33 -20 -33 -32 29 -45 4.97
Net Cash From Continuing Financing Activities
21 -47 1.40 -33 -20 -33 -32 29 -45 4.97
Issuance of Debt
98 62 156 46 233 113 60 125 55 107
Repayment of Debt
-62 -97 -138 -64 -235 -127 -73 -75 -82 -83
Payment of Dividends
-14 -13 -13 -15 -18 -19 -19 -19 -19 -18
Other Financing Activities, Net
- - -3.63 - -0.23 0.01 0.00 -1.90 - -1.53
Effect of Exchange Rate Changes
-0.01 -0.01 0.00 0.02 -0.03 0.10 -0.07 0.06 0.02 -0.49
Cash Interest Paid
9.16 7.13 15 12 17 12 18 13 17 13
Cash Income Taxes Paid
- - 0.53 - - 0.14 1.26 - - 0.08

Annual Balance Sheets for Crescent Capital BDC

This table presents Crescent Capital BDC's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Total Assets
2,515 1,303 1,627 1,656
Cash and Due from Banks
- 6.40 7.78 10
Restricted Cash
- 11 17 29
Trading Account Securities
- 8.15 1,587 4.82
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00
Other Assets
2,515 1,268 1.46 1,600
Total Liabilities & Shareholders' Equity
0.00 1,303 1,627 1,656
Total Liabilities
0.00 690 885 916
Other Short-Term Payables
- 5.86 3.45 3.71
Long-Term Debt
0.00 654 845 876
Other Long-Term Liabilities
0.00 18 21 21
Commitments & Contingencies
- 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
0.00 613 743 741
Total Preferred & Common Equity
0.00 613 743 741
Preferred Stock
- 0.00 0.00 0.00
Total Common Equity
0.00 613 743 741
Common Stock
- 675 966 959
Retained Earnings
- -62 -223 -218

Quarterly Balance Sheets for Crescent Capital BDC

This table presents Crescent Capital BDC's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
1,339 1,631 1,625 1,624 1,620 1,672 1,645
Cash and Due from Banks
13 21 7.54 6.00 6.74 11 17
Restricted Cash
9.41 13 14 17 25 25 21
Trading Account Securities
- 7.51 7.07 8.85 4.71 2.77 1.40
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
1,317 23 1,584 28 21 23 1,595
Total Liabilities & Shareholders' Equity
1,339 1,631 1,625 1,624 1,620 1,672 1,645
Total Liabilities
717 913 899 894 869 920 896
Other Short-Term Payables
- - 3.24 - - - 3.76
Long-Term Debt
691 883 859 864 840 891 857
Other Long-Term Liabilities
25 30 23 30 29 29 21
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
623 718 726 730 752 752 749
Total Preferred & Common Equity
623 718 726 730 752 752 749
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
623 718 726 730 752 752 749
Common Stock
666 788 788 788 966 966 966
Retained Earnings
-44 -70 -63 -58 -214 -213 -217

Annual Metrics and Ratios for Crescent Capital BDC

This table displays calculated financial ratios and metrics derived from Crescent Capital BDC's official financial filings.

Metric 2021 2022 2023 2024
Growth Metrics
- - - -
Revenue Growth
638.18% -100.00% 0.00% 0.00%
EBITDA Growth
396.17% -107.29% -1.04% -25.05%
EBIT Growth
496.17% -100.00% 0.00% 0.00%
NOPAT Growth
-21.30% -100.00% 0.00% 0.00%
Net Income Growth
44.39% -154.95% 100.61% -6,125.86%
EPS Growth
-7.22% 15.57% 19.17% 4.35%
Operating Cash Flow Growth
-155.11% 117.73% 230.21% -36.18%
Free Cash Flow Firm Growth
0.00% 151.23% -125.67% 90.92%
Invested Capital Growth
0.00% -49.63% 25.29% 1.83%
Revenue Q/Q Growth
0.00% 0.00% 100.00% -100.00%
EBITDA Q/Q Growth
0.00% 0.00% 93.35% -157.96%
EBIT Q/Q Growth
0.00% 0.00% 100.00% -100.00%
NOPAT Q/Q Growth
0.00% 0.00% 100.00% -100.00%
Net Income Q/Q Growth
0.00% 0.00% 100.36% -278.49%
EPS Q/Q Growth
0.00% 0.00% 4.07% -2.83%
Operating Cash Flow Q/Q Growth
0.00% 121.89% -7.28% -38.89%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 98.18%
Invested Capital Q/Q Growth
0.00% 0.00% 6,612,903.38% 0.65%
Profitability Metrics
- - - -
EBITDA Margin
84.25% 0.00% 0.00% 0.00%
EBIT Margin
94.72% 0.00% 0.00% 0.00%
Profit (Net Income) Margin
94.72% 0.00% 0.00% 0.00%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
100.00% 0.00% 0.00% 0.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
6.28% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
6.28% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% -14.16% 0.04% -2.14%
Cash Return on Invested Capital (CROIC)
-193.72% 66.00% -22.45% -1.82%
Operating Return on Assets (OROA)
3.14% 0.00% 0.00% 0.00%
Return on Assets (ROA)
3.14% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
0.00% -14.16% 0.04% -2.14%
Return on Equity Simple (ROE_SIMPLE)
0.00% -7.08% 0.04% -2.14%
Net Operating Profit after Tax (NOPAT)
79 0.00 0.00 0.00
NOPAT Margin
94.72% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
0.00% 2.74% -0.04% 1.84%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
5.28% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
79 0.00 0.00 0.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
70 -5.12 -5.17 -6.46
Valuation Ratios
- - - -
Price to Book Value (P/BV)
0.00 0.51 0.78 0.96
Price to Tangible Book Value (P/TBV)
0.00 0.51 0.78 0.96
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 2,192.89 0.00
Dividend Yield
13.51% 17.55% 11.63% 10.61%
Earnings Yield
0.00% 0.00% 0.05% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.75 0.88 0.96
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 34.07 15.14 26.29
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.76 0.00 0.00
Leverage & Solvency
- - - -
Debt to Equity
0.00 1.07 1.14 1.18
Long-Term Debt to Equity
0.00 1.07 1.14 1.18
Financial Leverage
0.00 5.17 1.11 1.16
Leverage Ratio
0.00 6.23 2.16 2.21
Compound Leverage Factor
0.00 0.00 0.00 0.00
Debt to Total Capital
0.00% 51.65% 53.22% 54.18%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 51.65% 53.22% 54.18%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 48.35% 46.78% 45.82%
Debt to EBITDA
0.00 -127.92 -163.43 -135.49
Net Debt to EBITDA
0.00 -124.59 -158.70 -129.40
Long-Term Debt to EBITDA
0.00 -127.92 -163.43 -135.49
Debt to NOPAT
0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - -
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
-2,436 1,248 -320 -29
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00
Efficiency Ratios
- - - -
Asset Turnover
0.03 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - -
Invested Capital
2,515 1,267 1,587 1,616
Invested Capital Turnover
0.07 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
2,515 -1,248 320 29
Enterprise Value (EV)
0.00 952 1,397 1,549
Market Capitalization
0.00 315 577 712
Book Value per Share
$0.00 $19.83 $20.04 $19.98
Tangible Book Value per Share
$0.00 $19.83 $20.04 $19.98
Total Capital
0.00 1,267 1,587 1,616
Total Debt
0.00 654 845 876
Total Long-Term Debt
0.00 654 845 876
Net Debt
0.00 637 820 836
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
0.00 43 -0.26 16
Net Nonoperating Obligations (NNO)
2,515 654 845 876
Total Depreciation and Amortization (D&A)
-8.73 -5.12 -5.17 -6.46
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
$0.00 $1.93 $2.30 $2.40
Adjusted Weighted Average Basic Shares Outstanding
0.00 30.89M 35.93M 37.06M
Adjusted Diluted Earnings per Share
$0.00 $1.93 $2.30 $2.40
Adjusted Weighted Average Diluted Shares Outstanding
0.00 30.89M 35.93M 37.06M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 30.89M 37.06M 37.06M
Normalized Net Operating Profit after Tax (NOPAT)
55 0.00 0.00 0.00
Normalized NOPAT Margin
66.31% 0.00% 0.00% 0.00%
Pre Tax Income Margin
94.72% 0.00% 0.00% 0.00%
Debt Service Ratios
- - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00
Payout Ratios
- - - -
Dividend Payout Ratio
60.46% -127.45% 24,543.73% -474.73%
Augmented Payout Ratio
61.12% -127.45% 24,543.73% -474.73%

Quarterly Metrics and Ratios for Crescent Capital BDC

This table displays calculated financial ratios and metrics derived from Crescent Capital BDC's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
-100.00% 0.00% -100.00% 100.00% 100.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth
62.29% 0.00% -102.58% 96.05% 93.69% 88.31% -29.19% -93.38% 477.70% -340.34%
EBIT Growth
100.00% 0.00% -100.00% 100.00% 100.00% 100.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Growth
100.00% 0.00% -100.00% 100.00% 100.00% 100.00% 0.00% 0.00% 0.00% 0.00%
Net Income Growth
-544.73% 0.00% -118.15% 107.82% 105.27% 133.41% 143.81% -206.09% -281.85% -316.93%
EPS Growth
15.56% 0.00% 38.46% 12.00% 13.46% 17.31% 16.67% 5.36% 8.47% -11.48%
Operating Cash Flow Growth
0.00% 136.78% 43.35% 390.57% 218.22% -17.31% 146.74% -221.14% 119.82% -108.35%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 100.19% 0.00% -5,489,327.66% -23,525,510.03% -6,671,974.99% 89.51%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00% 0.00% 25.29% 5,489,227.66% 23,525,610.03% 6,690,663.48% 1.83%
Revenue Q/Q Growth
100.00% 0.00% 100.00% -100.00% -100.00% 0.00% -100.00% 0.00% 529.82% -200.00%
EBITDA Q/Q Growth
95.61% -1,591.69% 97.90% 92.92% -300.00% -43.79% -129.59% -160.48% 251.67% -267.64%
EBIT Q/Q Growth
100.00% 0.00% 100.00% 100.00% -100.00% 0.00% -100.00% -100.00% 529.82% -200.00%
NOPAT Q/Q Growth
100.00% 0.00% 100.00% 100.00% -100.00% 0.00% -100.00% -100.00% 529.82% -200.00%
Net Income Q/Q Growth
1.94% -31.72% 84.68% -97.81% -31.00% 700.21% -44.26% 0.00% -18.28% -854.60%
EPS Q/Q Growth
4.00% 0.00% 3.85% 3.70% 5.36% 3.39% 3.28% 0.00% 8.47% -15.63%
Operating Cash Flow Q/Q Growth
-158.07% 331.68% -61.75% 27.05% 4.99% 62.06% 14.14% 0.00% 290.52% -106.16%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 99.90% -98.00% -1,334,760.86% -20,467.03% -39,312.72% -144,797.96% 97.90%
Invested Capital Q/Q Growth
0.00% 0.00% -462.51% 124.09% -111.43% 6,612,903.38% 26,530,182.33% 1,273,864.77% 603,676.02% 0.65%
Profitability Metrics
- - - - - - - - - -
EBITDA Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 71.75% 0.00%
EBIT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 0.00%
Profit (Net Income) Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -27.52% 0.00%
Tax Burden Percent
100.00% 108.42% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
0.00% 152.73% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -27.52% 262.69%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.58% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.11% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.13% 0.00%
Return on Equity (ROE)
0.00% -14.16% 0.00% 0.00% 0.00% 0.04% 0.00% 0.00% 1.70% -2.14%
Cash Return on Invested Capital (CROIC)
0.00% 98.52% 0.00% 0.00% 0.00% -22.45% -99.09% 1.41% -99.45% -1.82%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.20% 0.00%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.60% 0.00%
Return on Common Equity (ROCE)
0.00% -14.16% 0.00% 0.00% 0.00% 0.04% 0.00% 0.00% 1.70% -2.14%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.93% 1.55% 1.19% 0.00%
Net Operating Profit after Tax (NOPAT)
0.00 -15 0.00 0.00 0.00 0.00 0.00 0.00 4.51 -4.51
NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 70.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
0.00% 1.26% -68,461.49% -40,454.40% 8,123.44% -1.04% -1.04% 0.34% 1.47% 1.44%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
0.00 -14 0.00 0.00 0.00 0.00 0.00 0.00 6.44 -6.44
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-0.89 -15 -1.38 -0.80 -1.22 -1.76 -1.79 -1.55 4.62 -7.75
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.51 0.00 0.00 0.00 0.78 0.78 0.00 0.89 0.96
Price to Tangible Book Value (P/TBV)
0.00 0.51 0.00 0.00 0.00 0.78 0.78 0.00 0.89 0.96
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 2,242.77 0.00 37.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 2,192.89 40.57 0.00 75.30 0.00
Dividend Yield
15.86% 17.55% 15.54% 13.20% 11.56% 11.63% 12.00% 11.39% 11.36% 10.61%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.05% 2.46% 0.00% 1.33% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.75 0.00 67,909.39 0.00 0.88 0.88 0.00 0.93 0.96
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 5,315.82 0.00 82.34 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 133.41 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 5,315.82 0.00 82.34 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 96.16 0.00 167.58 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 34.07 10.54 7.89 5.54 15.14 12.07 0.00 15.44 26.29
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 1.07 0.00 0.00 0.00 1.14 1.12 1.18 1.14 1.18
Long-Term Debt to Equity
0.00 1.07 0.00 0.00 0.00 1.14 1.12 1.18 1.14 1.18
Financial Leverage
0.00 1.07 0.00 0.00 0.00 1.11 1.12 1.18 1.14 1.16
Leverage Ratio
0.00 6.23 0.00 0.00 0.00 2.16 2.16 2.22 2.20 2.21
Compound Leverage Factor
0.00 9.52 0.00 0.00 0.00 0.00 0.00 0.00 -0.60 5.82
Debt to Total Capital
0.00% 51.65% 100.00% 100.00% 100.00% 53.22% 52.78% 54.21% 53.38% 54.18%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 51.65% 100.00% 100.00% 100.00% 53.22% 52.78% 54.21% 53.38% 54.18%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 48.35% 0.00% 0.00% 0.00% 46.78% 47.22% 45.79% 46.62% 45.82%
Debt to EBITDA
0.00 -127.92 0.00 0.00 0.00 -163.43 -158.22 167.92 76.86 -135.49
Net Debt to EBITDA
0.00 -124.59 0.00 0.00 0.00 -158.70 -152.21 161.11 73.47 -129.40
Long-Term Debt to EBITDA
0.00 -127.92 0.00 0.00 0.00 -163.43 -158.22 167.92 76.86 -135.49
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 57.79 76.63 96.55 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 55.59 73.52 92.29 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 57.79 76.63 96.55 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 0.03 -0.01 0.02 -320 -1,592 -1,643 -1,602 -34
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
0.00 1,267 -0.03 0.01 -0.02 1,587 1,592 1,643 1,606 1,616
Invested Capital Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.00
Increase / (Decrease) in Invested Capital
0.00 0.00 -0.03 0.01 -0.02 320 1,592 1,643 1,606 29
Enterprise Value (EV)
0.00 952 346 474 551 1,397 1,398 0.00 1,488 1,549
Market Capitalization
0.00 315 346 474 551 577 590 0.00 669 712
Book Value per Share
$0.00 $19.83 $0.00 $0.00 $0.00 $20.04 $20.28 $20.30 $20.20 $19.98
Tangible Book Value per Share
$0.00 $19.83 $0.00 $0.00 $0.00 $20.04 $20.28 $20.30 $20.20 $19.98
Total Capital
0.00 1,267 -0.12 -0.06 -0.06 1,587 1,592 1,643 1,606 1,616
Total Debt
0.00 654 -0.12 -0.06 -0.06 845 840 891 857 876
Total Long-Term Debt
0.00 654 -0.12 -0.06 -0.06 845 840 891 857 876
Net Debt
0.00 637 -0.12 -0.06 -0.06 820 808 855 819 836
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
18 8.28 9.93 -1.41 -0.98 -7.80 -4.35 1.50 6.28 12
Net Nonoperating Obligations (NNO)
0.00 654 -0.03 0.01 -0.02 845 840 891 857 876
Total Depreciation and Amortization (D&A)
-0.89 -0.95 -1.38 -0.80 -1.22 -1.76 -1.79 -1.55 -1.82 -1.31
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.52 $0.52 $0.54 $0.56 $0.59 $0.61 $0.63 $0.59 $0.64 $0.54
Adjusted Weighted Average Basic Shares Outstanding
30.89M 30.89M 32.47M 37.06M 37.06M 35.93M 37.06M 37.06M 37.06M 37.06M
Adjusted Diluted Earnings per Share
$0.52 $0.52 $0.54 $0.56 $0.59 $0.61 $0.63 $0.59 $0.64 $0.54
Adjusted Weighted Average Diluted Shares Outstanding
30.89M 30.89M 32.47M 37.06M 37.06M 35.93M 37.06M 37.06M 37.06M 37.06M
Adjusted Basic & Diluted Earnings per Share
($0.08) $0.00 $0.24 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
30.89M 30.89M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M
Normalized Net Operating Profit after Tax (NOPAT)
0.00 -15 0.00 0.00 0.00 0.00 0.00 0.00 4.51 -4.51
Normalized NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 70.00% 0.00%
Pre Tax Income Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -27.52% 0.00%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% -127.45% -48.29% -315.91% -81.14% 24,543.73% 486.88% 643.88% 851.51% -474.73%
Augmented Payout Ratio
0.00% -127.45% -48.29% -315.91% -81.14% 24,543.73% 486.88% 643.88% 851.51% -474.73%

Frequently Asked Questions About Crescent Capital BDC's Financials

When does Crescent Capital BDC's financial year end?

According to the most recent income statement we have on file, Crescent Capital BDC's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Crescent Capital BDC's net income changed over the last 3 years?

Crescent Capital BDC's net income appears to be on a downward trend, with a most recent value of -$15.85 million in 2024, falling from $78.94 million in 2021. The previous period was $263 thousand in 2023.

How has Crescent Capital BDC revenue changed over the last 3 years?

Over the last 3 years, Crescent Capital BDC's total revenue changed from $83.34 million in 2021 to $0.00 in 2024, a change of -100.0%.

How much debt does Crescent Capital BDC have?

Crescent Capital BDC's total liabilities were at $915.64 million at the end of 2024, a 3.5% increase from 2023, and a 91,563,700,000.0% increase since 2021.

How much cash does Crescent Capital BDC have?

In the past 3 years, Crescent Capital BDC's cash and equivalents has ranged from $0.00 in 2021 to $10.13 million in 2024, and is currently $10.13 million as of their latest financial filing in 2024.

How has Crescent Capital BDC's book value per share changed over the last 3 years?

Over the last 3 years, Crescent Capital BDC's book value per share changed from 0.00 in 2021 to 19.98 in 2024, a change of 1,998.4%.



This page (NASDAQ:CCAP) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners